Author:
Rothfuss Andreas,O’Donovan Mike,De Boeck Marlies,Brault Dominique,Czich Andreas,Custer Laura,Hamada Shuichi,Plappert-Helbig Ulla,Hayashi Makoto,Howe Jonathan,Kraynak Andrew R.,van der Leede Bas-jan,Nakajima Madoka,Priestley Catherine,Thybaud Veronique,Saigo Kazuhiko,Sawant Satin,Shi Jing,Storer Richard,Struwe Melanie,Vock Esther,Galloway Sheila
Subject
Health, Toxicology and Mutagenesis,Genetics
Reference83 articles.
1. ICH S2A, Guidance on Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals, 1994.
2. ICH S2(R1) Genotoxicity: Testing and Data Interpretation for Pharmaceuticals Intended for Human Use, Step 2 Document, 2008, http://www.ich.org/LOB/media/MEDIA4474.pdf (link checked January 2010).
3. Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS harmonized scheme;Eastmond;Mutagenesis,2009
4. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo;Kirkland;Mutat. Res.,2008
5. Guidance on information requirements and chemical safety assessment, Ch. R.7a: Endpoint Specific Guidance. See chapter R.7.7.1 Mutagenicity Testing, 374-402, http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_r7a_en.pdf?vers=20_08_08.(link checked January 2010).
Cited by
97 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献